Mydriasis is the abnormal or excessive dilation (widening) of the pupil beyond its normal response to light and accommodation, occurring unilaterally or bilaterally and resulting from a disruption in the autonomic innervation of the iris. It is the clinical opposite of miosis (pupillary constriction) and should be distinguished from anisocoria, which describes unequal pupil sizes regardless of cause. The underlying mechanism involves either paralysis or impairment of the parasympathetic iris sphincter muscle (via CN III or ciliary ganglion dysfunction), overstimulation of the sympathetic iris dilator muscle, or direct pharmacologic blockade of muscarinic acetylcholine receptors — classically with tropicamide, atropine, or cyclopentolate. Mydriasis can be physiological (e.g., normal response to low light, fear, or strong emotion) or pathological (e.g., CN III palsy, herniation syndrome, traumatic iridoplegia, pharmacologic exposure, Adie’s tonic pupil). Clinically relevant subtypes encountered in coding include pharmacologic mydriasis (intentional dilation for exam or surgery), traumatic mydriasis, and mydriasis secondary to neurological lesions — all of which may carry additional etiology codes beyond H57.04. It is commonly confused with tonic pupil (H57.05x), which also presents with dilation but is specifically characterized by light-near dissociation and sector palsy of the iris sphincter.
“mass of red-hot metal,” “glowing forge material” — root noun; possibly referencing the bright, sparkling appearance of a widely dilated pupil, or the red-eye reflex seen on flash photography
Noun-forming suffix — “abnormal condition of,” “morbid state of” — used to form nouns denoting a pathological process or state
The word entered English in the 1690s as mydriasis (noun), borrowed directly from Latin mydriasis, from Ancient Greek μυδρίᾱσις (mudríāsis) — literally “abnormal condition of the glowing/dilated [pupil].” The etymology of the root μύδρος (múdros, “mass of red-hot material”) is uncertain but is thought to reference the pupil’s bright appearance when widely dilated, or possibly the red-eye effect observed when a dilated eye is exposed to a flash of light. The root mydri- is relatively narrow in productivity but directly generates the adjectival/pharmacological form mydriatic (causing or pertaining to dilation of the pupil) and its antonym family through miosis / miotic. The suffix -asis is highly productive across medical terminology: psoriasis, elephantiasis, ptosis (via related suffix), and amaurosis.
🔀 ALIASES / ALTERNATE TERMS
Mydriatic(adjective form — appears clinically as “mydriatic drops,” “mydriatic agent,” “mydriatic examination”; used to describe any drug or condition that causes pupillary dilation)
Dilated pupil(lay and clinical synonym; used in patient-facing documentation, nursing notes, and neurological assessment records)
Pharmacologic dilation(intentional, drug-induced mydriasis performed prior to funduscopic examination or intraocular surgery; coded as H57.04 when documented as the clinical finding; the agent may be coded separately)
Fixed dilation(clinical descriptor indicating non-reactive mydriasis — pupil does not constrict to light or near stimulus; associated with severe CN III palsy, herniation, or pharmacologic blockade; coded H57.04 with additional etiology codes as indicated)
Traumatic mydriasis(mydriasis resulting from blunt or penetrating ocular trauma; typically coded with injury codes — e.g., S05.xx — sequenced first as the etiology, with H57.04 as a manifestation)
Congenital mydriasis(rare form present at birth; classified under H57.04 per ICD-10-CM synonyms; consider additional congenital anomaly codes if syndromic)
Adie’s tonic pupil(related but distinct: a post-ganglionic parasympathetic denervation causing tonic/sluggish dilation with light-near dissociation; classified separately under H57.051-H57.059)
Anticholinergic mydriasis(pharmacologic subtype due to muscarinic receptor blockade — atropine, tropicamide, scopolamine; also seen in toxidrome settings)
Adrenergic mydriasis(pharmacologic subtype due to α1-receptor overstimulation — phenylephrine, cocaine; less complete dilation; near/light reflex typically preserved)
Neurogenic mydriasis(dilation secondary to CN III palsy, Horner’s syndrome reversal, or central herniation; workup-driven; code the neurological etiology first)
🔗 RELATED TERMS
miosis — the direct opposite of mydriasis; refers to abnormal constriction of the pupil (< 2 mm); coded H57.03; caused by parasympatheticoveractivation, opioid toxicity, Horner’s syndrome, or pilocarpine use
Anisocoria — unequal pupil sizes between the two eyes; does not specify which pupil is abnormal; coded H57.02; mydriasis may be the cause of anisocoria when the dilated pupil is the pathological one
tonic pupil — a specific post-ganglionic parasympathetic lesion causing poorly reactive, dilated pupil with light-near dissociation and segmental iris palsy; coded H57.051 (right), H57.052 (left), H57.053 (bilateral), H57.059 (unspecified); distinguished from mydriasis by its characteristic slow, tonic re-dilation after near effort
Adie syndrome — the systemic form of tonic pupil combined with diminished deep tendon reflexes; coded H57.051-H57.059 for the pupil component; CNS involvement may warrant additional neurological codes
Cycloplegia — paralysis of the ciliary muscle causing loss of accommodation, often co-occurring with pharmacologic mydriasis; both mydriasis and cycloplegia are induced by the same anticholinergic agents (atropine, cyclopentolate); cycloplegic refraction billed under 92015
Mydriatic — the adjectival form; refers to an agent or condition that produces mydriasis; “mydriatic drugs” include tropicamide, phenylephrine, atropine, and cyclopentolate
Iris sphincter rupture — traumatic disruption of the iris sphincter muscle causing fixed, irregular mydriasis; distinct from neurogenic/pharmacologic causes; sequenced with the appropriate trauma code
CN III palsy — oculomotornerve palsy; causes ptosis, exotropia/hypotropia (“down-and-out” gaze), and a dilated non-reactive pupil; coded under G52.8 or cranial nerve disease category; mydriasis is the manifestation coded with H57.04
Herniation syndrome — transtentorial or uncal herniation compresses CN III, producing sudden unilateral fixed mydriasis; a neurosurgical emergency; the herniation is coded first, H57.04 as manifestation
Pharmacologic pupil — clinical term for a dilated, non-reactive pupil due to topical anticholinergic exposure; differentiated from CN III palsy by failure to constrict with 1% pilocarpine
Funduscopic examination — primary diagnostic procedure requiring pharmacologic mydriasis; documented as part of comprehensive/intermediate eye exams billed under 92004, 92014, 92002, 92012
Pupillary light reflex — the autonomic reflex tested to evaluate mydriasis; afferent arc via CN II, efferent arc via CN III; absent or sluggish in pathologic mydriasis
CODING CORNER
🏥 ICD-10-CM CODES
Anomalies of Pupillary Function (H57.0x — Pupillary Anomalies)
Code
Description
H57.0-
Anomalies of pupillary function — parent/category code, NOT billable
Fundus photography with interpretation and report; requires pharmacologic dilation in most clinical settings; documents fundus finding driving the mydriasis workup
Visual field examination, extended (threshold); companion test when mydriasis is associated with optic nerve or neurological pathology
95930
Visual evoked potential (VEP) testing; companion neurodiagnostic study when mydriasis is of neurogenic origin (CN III palsy, demyelinating disease)
⚠️ Coding Note:H57.04 is a single, non-laterality-specific code — unlike most ophthalmic codes, mydriasis does not require a laterality 7th character, so the same code applies whether the finding is unilateral or bilateral; document which eye(s) are affected clinically, but the code itself does not bifurcate. When mydriasis is a manifestation of an underlying neurologic etiology (e.g., CN III palsy, transtentorial herniation, or Adie’s tonic pupil), sequence the etiology code first and use H57.04 as an additional code per ICD-10-CM’s etiology/manifestation convention — do not code H57.04 as the principal diagnosis in those encounters. A critical undercoding alert for inpatient profee settings: when a provider documents “fixed dilated pupil,” “blown pupil,” or “non-reactive pupil” in the context of neurological decline, query for the specific neurological etiology (CN III compression, herniation, intracranial hypertension) rather than accepting only H57.04 — the underlying diagnosis may drive DRG assignment and medical necessity for neuroimaging. Pharmacologic mydriasis administered as a therapeutic agent during the visit is an integral component of comprehensive and intermediate eye exam codes (92004, 92014, 92002, 92012) per CPT descriptor and is not separately billable — billing a drug administration code (e.g., 99211/J-code for drops) in addition to the eye exam code for routine diagnostic dilation creates an unbundling risk. When mydriasis is associated with an adverse effect of a prescribed anticholinergic or sympathomimetic drug (correct drug, correct dose), code the adverse effect with T44.3X5A (initial) sequenced after the manifestation code H57.04, per ICD-10-CM adverse effect sequencing rules.